Minnesota 2025-2026 Regular Session

Minnesota Senate Bill SF164

Introduced
1/16/25  
Refer
1/16/25  
Refer
2/24/25  

Caption

Public postsecondary institutions maintenance of a supply of opiate antagonists on system campuses requirement

Impact

The bill amends existing Minnesota statutes regarding the administration of opiate antagonists, aiming to enhance safety measures on college campuses where opioid use and related fatalities can be a concern. By ensuring that institutions are equipped with opiate antagonists, the legislation seeks to reduce the risk of deaths from overdoses and improve overall campus health and safety. The bill also encourages training programs for staff to properly recognize signs of overdose and administer the medication effectively during emergencies.

Summary

SF164 is a legislative bill designed to require public postsecondary institutions in Minnesota to maintain a supply of opiate antagonists on their campuses. The bill mandates that each campus must have at least two doses of a nasal opiate antagonist available in residential facilities. It also establishes guidelines for training and implementation regarding the use of these life-saving medications in emergency situations related to opiate overdoses.

Sentiment

The sentiment surrounding SF164 appears to be largely positive, with broad support from educational institutions and public health advocates who recognize the importance of addressing the opioid crisis. Stakeholders appreciate the proactive approach of providing campuses with essential resources to intervene during overdose situations. However, there may be some concerns regarding the logistics of storing and managing these substances on campuses and ensuring staff are adequately trained.

Contention

While the bill enjoys general support, potential points of contention might arise regarding implementation details, such as the costs of maintaining medication supplies and training personnel. Moreover, discussions could address the adequacy of opioid crisis response measures on campuses and the need for further educational initiatives surrounding substance abuse and mental health. The practical implications of how institutions enforce and manage these new requirements may also generate debate.

Companion Bills

MN HF862

Similar To Public postsecondary institutions required to maintain a supply of opiate antagonists on system campuses.

Previously Filed As

MN SF5480

Public postsecondary institutions maintenance of a supply of opiate antagonists on system campuses requirement

MN HF5400

Public postsecondary institutions required to maintain supply of opiate antagonists on system campuses.

MN SF2444

Schools requirement to maintain a supply of opiate antagonists

MN HF2398

Schools required to maintain supply of opiate antagonists, provisions modified for opiate antagonist administration in schools, and money appropriated.

MN HF1465

Administration of opiate antagonists for drug overdose provision changed.

MN SF2339

Provision modification of administration of opiate antagonists for drug overdose

MN SF3484

Nasal opiate antagonists in certain first aid kits requirement

MN HF3590

Education; nasal opiate antagonists required in first aid kits.

MN SF1176

Licensed pharmacists authority to initiate, order and administer vaccines and certain medical and laboratory tests; coverage under medical assistance requirement

MN HF1126

Postsecondary attainment goals, student financial aid, institutional licensure provisions, and institutional grant program policy changes provided.

Similar Bills

CA AB24

Emergency response: opioid antagonist kits.

CA SB472

Pupil health: opioid overdose reversal medication.

CA SB234

Opioid antagonists: stadiums, concert venues, and amusement parks.

CA AB19

Pupil health: opioid antagonists.

CA AB3271

Pupil health: opioid antagonists.

CA AB915

Pupil health: drug education: opioid overdose training program.

CA AB1915

Pupil health: drug education: opioid overdose training program.